Amneal Pharmaceuticals Executive and Leadership Team

Hiral Kuvadia, the Chief of Staff To President at Amneal Pharmaceuticals, coordinates high-level strategic initiatives across the entire enterprise. Kuvadia manages executive communications and aligns departmental objectives with the broader corporate mission of delivering essential medicines. By facilitating cross-functional collaboration, the Chief of Staff To President ensures that leadership decisions translate into actionable operational outcomes. Kuvadia monitors key performance indicators to maintain organizational efficiency while supporting the President in navigating complex market challenges. This role involves synthesizing data from various business units to provide actionable insights for the executive team. Through rigorous oversight of internal processes, Hiral Kuvadia optimizes the flow of information between the C-suite and operational departments. Kuvadia maintains a focus on long-term growth strategies, ensuring that the company remains agile in the competitive pharmaceutical landscape. Ultimately, the Chief of Staff To President drives the execution of critical business priorities to sustain the company's market position.

Sanjay Jain, the President, Amneal (India) at Amneal Pharmaceuticals, architects the operational strategy for the company's significant manufacturing and research footprint in the region. Jain manages large-scale production facilities, ensuring that output aligns with global quality standards and supply chain demands. Overseeing the Indian operations, the President, Amneal (India) drives efficiency improvements and technological upgrades within the manufacturing plants. Sanjay Jain coordinates with the global leadership team to integrate regional production capabilities into the broader corporate portfolio. This leadership role involves fostering a culture of operational excellence and safety across all local sites. By optimizing resource allocation and labor productivity, Jain supports the company's ability to deliver affordable medicines to international markets. The President, Amneal (India) maintains a focus on scaling production capacity to meet the rising demand for complex injectables and generics. Through strategic management of local assets, Jain ensures that the Indian operations remain a cornerstone of the company's global success.

Upendra Singh, the President, Business & Emerging Markets (India) at Amneal Pharmaceuticals, executes the commercial strategy for expanding the company's presence in high-growth regions. Singh identifies new market opportunities and tailors the product portfolio to meet the specific needs of emerging economies. Overseeing business development, the President, Business & Emerging Markets (India) builds strategic alliances and distribution networks to enhance medicine accessibility. Upendra Singh analyzes regional market trends to inform product launches and pricing strategies. This role requires close collaboration with global marketing and regulatory teams to ensure seamless entry into new territories. By focusing on sustainable growth, Singh drives the adoption of the company's branded and generic offerings in diverse markets. The President, Business & Emerging Markets (India) manages the commercial lifecycle of products, from initial market assessment to full-scale distribution. Through targeted expansion efforts, Singh strengthens the company's footprint and contributes to the overall mission of making healthy possible on a global scale.

Jatin Savani, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) at Amneal Pharmaceuticals, directs the integrity of global manufacturing standards. Savani oversees compliance frameworks and supplier quality protocols to ensure every product meets stringent regulatory requirements. Managing external manufacturing partnerships, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) mitigates supply chain risks while maintaining production excellence. Jatin Savani also leads marketing strategies for the SETE division, focusing on expanding the reach of essential medicines into new territories. By integrating quality assurance with commercial outreach, Savani creates a cohesive approach to market penetration. The Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) balances technical compliance with aggressive growth targets. Through this dual focus, Savani secures the company's reputation for reliability and innovation in the global pharmaceutical sector.